MATWIN is pleased to announce that registrations are officially open for MEET2WIN 2026, the European partnering convention dedicated to innovation in oncology.

The 11th edition of MEET2WIN will take place on May 12–13, 2026, in Bordeaux (France), bringing together key stakeholders committed to accelerating the development of innovative solutions against cancer.

A unique partnering event focused on oncology innovation

Over two days, MEET2WIN offers a high-level environment designed to foster strategic meetings, collaborations and business opportunities across the oncology innovation value chain.

The event brings together:

• Start-ups and scale-ups in oncology

• Biotech and medtech companies

• Academic researchers and clinicians

• Pharmaceutical and industrial players

• Investors, TTOs and innovation support organizations

Through pre-qualified one-to-one meetings, plenary sessions and expert conferences, MEET2WIN aims to bridge the gap between research and market-driven innovation.

Early bird rates available until February 28

Participants can benefit from early bird registration fees until February 28, 2026. This preferential rate is an opportunity to secure participation early and maximize networking opportunities ahead of the event.

Why attend MEET2WIN 2026?

• Meet decision-makers and innovation leaders in oncology

• Identify scientific, clinical and industrial partners

• Explore emerging technologies and therapeutic approaches

• Gain insights into current trends and challenges in cancer innovation

Save the date

📅 May 12–13, 2026
📍 Bordeaux, France

MEET2WIN continues to position itself as a key European event for oncology partnering, supporting the emergence and growth of impactful cancer innovations.

👉 Registrations are open — join us for MEET2WIN 2026.